What is the proper role of oral antibiotics in the treatment of patients with chronic sinusitis?

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 21, Issue 1, 2013, Pages 61-68

  Adelson, Robert T ^a   Adappa, Nithin D ^b  

^a Albany ENT and Allergy   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antibiotics in chronic rhinosinusitis; chronic rhinosinusitis; macrolide antibiotics; odontogenic sinusitis; oral antibiotics

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; IMMUNOGLOBULIN E; ROXITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL LOAD; BACTERIAL SINUSITIS; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; CHRONIC RHINOSINUSITIS; CHRONIC SINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; DENTAL SURGERY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ERUPTION; ENDOSCOPIC SINUS SURGERY; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MINIMUM INHIBITORY CONCENTRATION; NOSE SECRETION; PERIODONTAL ABSCESS; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; TOOTH INFECTION; TOOTH PERIAPICAL DISEASE; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; ENDOSCOPY; HUMANS; SINUSITIS;

EID: 84872831939     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32835ac625     Document Type: Review

References (64)

1. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 2003; 129 (S):1-32.
2. Giklich RE, Metson R. Economic implications of chronic rhinosinusitis. Otolaryngol Head Neck Surg 1995; 113:104-109.
3. Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 2009; 242:1-157.
4. Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy 2009; 23:392-395.
5. Murphy MP, Fishman P, Short SO, et al. Healthcare utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organization. Otolaryngol Head Neck Surg 2002; 127:367-376.
6. Suh JD, Kennedy DW. Treatment options for chronic rhinosinusitis. Proc Am thorac Soc 2011; 8:132-140.
7. Bhattacharyya N. Bacterial infection in chronic rhinosinusitis: a controlled paired analysis. Am J Rhinol 2005; 19:544-548.
8. Niederfuhr A, Kirsche H, Riechelmann H, Wellinghausen N. The bacteriology of chronic rhinosinusitis with and without nasal polyps. Arch Otolaryngol Head Neck Surg 2009; 135:131-136.
9. Doyle PW, Woodham JD. Evaluation of the microbiology of chronic ethmoid sinusitis. J Clin Microbiol 1991; 29:2396-2400.
10. Toth L, Csomor P, Sziklai I, Karosi T. Biofilm detection in chronic rhinosinusitis by combined application of hematoxylin-eosin and gram staining. Eur Arch Otorhinolaryngol 2011; 268:1455-1462.
11. Hochstim CJ, Choi JY, Lowe D, et al. Biofilm detection with hematoxylin-eosin staining. Arch Otolaryngol Head Neck Surg 2010; 136:453-456.
12. Wood AJ, Fraser J, Swift S, et al. Are biofilms associated with an inflammatory response in chronic rhinosinusitis? Int Forum Allergy Rhinol 2011; 1:335-339.
13. Dubin MG, Liu C, Lin SY, Senior BA. American Rhinologic Society member survey on 'maximal medical therapy' for chronic rhinosinusitis. Am J Rhinol 2007; 21:483-488.
14. Kaszuba SM, Stewart MG. Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists. Am J Rhinol 2006; 20:186-190.
15. Ferguson BJ, Narita M, Yu VL, et al. Prospective observational study of chronic rhinosinusitis: environmental triggers and antibiotic implications. Clin Infect Dis 2011; 54:62-68.
16. Mandal R, Patel N, Ferguson BJ. Role of antibioics in sinusitis. Curr Opin Infect Dis 2012; 25:183-192.
17. Marple BF, Stankiewicz JA, Baroody FM, et al. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med 2009; 121:121-139.
18. Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol 2011; 128:693-707.
19. Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011; 86:427-443.
20. Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guidelines on adult sinusitis. Otolaryngol Head neck Surg 2007; 137:375-377.
21. Desrosiers M, Evans GA, Keith PK. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otol Head Neck Surh 2011; 40 (S2):99-142.
22. Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Data Syst Rev 2011; 5:1-27.
23. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for Otorhinolaryngologists. Rhinology 2012; 50 (Suppl 23):1-298.
24. Soler ZM, Oyer SL, Kern RC, et al. Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidence-based review with recommendations. Int Forum Allergy Rhino 2012 [Epub ahead of print].
25. Guss J, Abuzeid WM, Doghramji L, et al. Fluroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec 2009; 71:263-267.
26. Kingdom TT, Swain RE. The microbiology and antimicrobial resistance patterns in chronic rhinosinusitis. Am J Otolaryngol 2004; 25:323-328.
27. Bhattacharyya N, Kepnes LJ. Assessment of trends in antimicrobial resistance in chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2008; 117:448-452.
28. Bhattacharyya N, Kepnes LJ. The risk of development of antimicrobial resistance in individual patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2004; 130:1201-1204.
29. Genoway KA, Philpott CM, Javer AR. Pathogen yield and antimicrobial resistance patterns of chronic rhinosinusitis patients presenting to a tertiary rhinology centre. J Otolaryngol Head Neck Surg 2011; 40:232-237.
30. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005:CD003539.
31. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125:1069-1076.
32. Portela RA, Hootnick J, McGinn J. Perioperative care in functional endoscopic sinus surgery: a suvey study. Int Forum Allergy Rhinol 2012; 2:27-33.
33. Albu S, Lucaciu R. Prophylactic antibiotics in endoscopic sinus surgery: a short follow-up study. Am J Rhinol Allergy 2010; 24:306-309.
34. Rudmik L, Soler ZM, Orlandi RR, et al. Early postoperative care following endoscopic sinus surgery: An evidence based review with recommendations. Int Forum Allergy Rhinol 2011; 1:417-430.
35. Wilson DN. On the specificity of antibiotics targeting the large ribosomal subunit. Ann NY Acad Sci 2011; 1241:1-16.
36. Tamaoki J. The effects of macrolides on inflammatory cells. Chest 2004; 125:41S-50S.
37. Kudoh S, Uetake T, Hagiwara M, et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987; 25:632-642.
38. Rhee CS, Majima Y, Arima S, et al. Effects of clarithromycin on rheologic properties of nasal mucus in patients with chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2000; 109:484-487.
39. Rubin BK, Druce H, Ramirez OE, Palmer R. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997; 155:2018-2023.
40. Tamaoki J, Takeyama K, Tagaya E, Kono K. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 1995; 39:1688-1690.
41. Baumann U, Fischer JJ, Gudowius P, et al. Buccal adherence of Pseudomonas aerugnoas in patients with cystic fibrosis under long term therapy with azithromycin. Infection 2001; 29:7-11.
42. Tateda K, Comte R, Pechere JC, et al. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001; 45:1930-1933.
43. Kobayashi H, Kobayashi O, Kasai S. Pathogenesis and clinical manifestations of chronic colonization by Pseudomonas aeruginosa and its biofilms in the airway tract. J Infect Chemother 2009; 15:125-142.
44. Kanoh S, Rubin BK.Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbial Rev 2010; 23:590-615
45. Harvey RJ, Wallwork BD, Lund VJ. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis. Immunol Allergy Clin N AM 2009; 29: 689-703.
46. Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011; 66:1457-1468.
47. Cervin A, Wallwork B, MacKay-Sim A, et al. Effects of long-termclarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis. Clin Physiol Funct Imaging 2009; 29:136-142.
48. Haruna S, Chimada C, Ozawa M, et al. A study of poor responders for longterm, low-dose macrolide administration for chronic sinusitis. Rhinology 2009; 47:66-71.
49. Wallwork B, Coman W, MacKay-Sim A, et al. A double-blind randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116:189-193.
50. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomized controlled trial. Laryngoscope 2004; 114:923-930.
51. Majima Y, Kurono Y, Hirakawa K, et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. Auris Nasus Larynx 2012; 39:38-47.
52. Soler ZM, Smith TL. What is the role of long-term macrolide therapy in the treatment of recalcitrant chronic rhinosinusitis? Laryngoscope 2009; 119:2083-2084.
53. Albu S, Baicut M. Failures in endoscopic surgery of the maxillary sinus. Otolaryngol Head Neck Surg 2010; 142:196-201.
54. Lee KC, Lee SJ. Clinical features and treatments of odontogenic sinusitis. Yonsei Med J 2010; 51:932-937.
55. Longhini AB, Ferguson BJ. Clinical aspects of odontogenic maxillary sinusitis: a case series. Int Forum Allergy Rhinol 2011; 1:409-415.
56. Albu S, Baciut M, Opincariu I, et al. The canine fossa puncture in chronic odontogenic maxillary sinusitis. Am J Rhinol 2011; 25:358-362.
57. Patel NA, Ferguson BJ. Odontogenic sinusitis: an ancient but underappreciated cause of maxillary sinusitis. Curr Opin Otolaryngol Head Neck Surg 2012; 20:24-28.
58. Mehra P, Jeong D. Maxillary sinusitis of odontogenic origin. Curr Allergy Asthma Rep 2009; 9:238-243.
59. Longhini AB, Branstetter BF, Ferguson BJ. Otolaryngologists' perception of odontogenic maxillary sinusitis. Laryngoscope 2012; 122:1910-1914.
60. Longhini AB, Branstetter BF, Ferguson BJ. Unrecognized odontogenic maxillary sinusitis: a cause of endoscopic sinus surgery failure. Am J Rhinol 2010; 24:296-310.
61. Young D, Morton R, Bartley J. Therapeutic ultrasound as treatment for chronic rhinosinusitis: preliminary observations. J Laryngol Otol 2010; 124:495-499.
62. Biel MA, Sievert C, Usacheva M. Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms. Int Forum Allergy Rhinol 2011; 1:329-334.
63. Li Z. Thermotherapy: a novel possible treatment strategy of chronic rhinosinusitis based on the chilblain-like alteration in the early pathophysiology. Med Hypotheses 2012; 78:67-68.
64. Cincik H, Ferguson BJ. The impact of endoscopic culture on care in rhinosinusitis. Laryngoscope 2006; 116:1562-1568.